G. CENGİZ SEVAL And M. BEKSAÇ, "The safety of bortezomib for the treatment of multiple myeloma," EXPERT OPINION ON DRUG SAFETY , vol.17, no.9, pp.953-962, 2018
CENGİZ SEVAL, G. And BEKSAÇ, M. 2018. The safety of bortezomib for the treatment of multiple myeloma. EXPERT OPINION ON DRUG SAFETY , vol.17, no.9 , 953-962.
CENGİZ SEVAL, G., & BEKSAÇ, M., (2018). The safety of bortezomib for the treatment of multiple myeloma. EXPERT OPINION ON DRUG SAFETY , vol.17, no.9, 953-962.
CENGİZ SEVAL, GÜLDANE, And MERAL BEKSAÇ. "The safety of bortezomib for the treatment of multiple myeloma," EXPERT OPINION ON DRUG SAFETY , vol.17, no.9, 953-962, 2018
CENGİZ SEVAL, GÜLDANE C. And BEKSAÇ, MERAL. "The safety of bortezomib for the treatment of multiple myeloma." EXPERT OPINION ON DRUG SAFETY , vol.17, no.9, pp.953-962, 2018
CENGİZ SEVAL, G. And BEKSAÇ, M. (2018) . "The safety of bortezomib for the treatment of multiple myeloma." EXPERT OPINION ON DRUG SAFETY , vol.17, no.9, pp.953-962.
@article{article, author={GÜLDANE CENGİZ SEVAL And author={MERAL BEKSAÇ}, title={The safety of bortezomib for the treatment of multiple myeloma}, journal={EXPERT OPINION ON DRUG SAFETY}, year=2018, pages={953-962} }